(PDF) An 8-Week Open Label Trial of L -Threonic Acid

An 8-Week Open Label Trial of L -Threonic Acid Magnesium Salt in Patients With Mild to Moderate Dementia

Personalized Medicine in Psychiatry

doi 10.1016/j.pmip.2017.07.001

Full Text

Open PDF

Abstract

Available in full text

Date

December 1, 2017

Authors

Publisher

Elsevier BV

Related search

Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia

Journal of Child and Adolescent Psychopharmacology

English

Effects of a Nutraceutical Combination of Fermented Red Rice, Liposomal Berberine, and Curcumin on Lipid and Inflammatory Parameters in Patients With Mild-To-Moderate Hypercholesterolemia: An 8-Week, Open-Label, Single-Arm Pilot Study

Archives of Medical Science - Atherosclerotic Diseases

2018

English

The Use of Alfa-Lipoic Acid-R (ALA-R) in Patients With Mild-Moderate Carpal Tunnel Syndrome: A Randomised Controlled Open Label Prospective Study

Malaysian Orthopaedic Journal

English

An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression

American Journal of Psychiatry

Psychiatry

Mental Health

2004

English

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

English

Changes of Immunogenic Profiles Between a Single Dose and One Booster Influenza Vaccination in Hemodialysis Patients – An 18-Week, Open-Label Trial

Scientific Reports

Multidisciplinary

2016

English

Rheopheresis in Patients With Ischemic Diabetic Foot Syndrome: Results of an Open Label Prospective Pilot Trial

Therapeutic Apheresis and Dialysis

Hematology

Nephrology

2003

English

A 24‐week Multicentre, Randomised, Open‐label, Parallel‐group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate‐to‐severe Plaque Psoriasis Naïve to Systemic Treatment

British Journal of Dermatology

Dermatology

Medicine

2020

English

Continuation Versus Discontinuation of Treatment for Severe Dementia: Randomized, Pragmatic, Open-Label, Clinical Trial to Evaluate the Efficacy of Continuing Drug Treatment in Patients With Severe Dementia (STOP-DEM)

English

Amanote Research

An 8-Week Open Label Trial of L -Threonic Acid Magnesium Salt in Patients With Mild to Moderate Dementia

Personalized Medicine in Psychiatry

doi 10.1016/j.pmip.2017.07.001

Full Text

Abstract

Date

Authors

Publisher

Related search

Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia

Effects of a Nutraceutical Combination of Fermented Red Rice, Liposomal Berberine, and Curcumin on Lipid and Inflammatory Parameters in Patients With Mild-To-Moderate Hypercholesterolemia: An 8-Week, Open-Label, Single-Arm Pilot Study

The Use of Alfa-Lipoic Acid-R (ALA-R) in Patients With Mild-Moderate Carpal Tunnel Syndrome: A Randomised Controlled Open Label Prospective Study

An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

Changes of Immunogenic Profiles Between a Single Dose and One Booster Influenza Vaccination in Hemodialysis Patients – An 18-Week, Open-Label Trial

Rheopheresis in Patients With Ischemic Diabetic Foot Syndrome: Results of an Open Label Prospective Pilot Trial

A 24‐week Multicentre, Randomised, Open‐label, Parallel‐group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate‐to‐severe Plaque Psoriasis Naïve to Systemic Treatment

Continuation Versus Discontinuation of Treatment for Severe Dementia: Randomized, Pragmatic, Open-Label, Clinical Trial to Evaluate the Efficacy of Continuing Drug Treatment in Patients With Severe Dementia (STOP-DEM)